valor de las acciones
Competidores
| Simbolo bursátil | Precio | Pronóstico 1A | Pronóstico 2A | Cap. Mercado | Div Yld | Tasa de crecimiento |
|---|---|---|---|---|---|---|
|
NYSE:ABBV
AbbVie
|
163.79 | -21.82% | -11.49% | 289,231.48 | 3.84% | 7.03% |
|
NasdaqGS:AMGN
Amgen
|
319.04 | -14.06% | -5.45% | 171,144.12 | 2.89% | 5.31% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.01 | 22.18% | 31.53% | 83,479.36 | 4.55% | 0.15% |
|
NasdaqGM:ALXN
Alexion Pharmaceuticals
|
182.50 | 0% | 0% | 40,336.01 | 0% | 0% |
|
NasdaqGS:BIIB
Biogen
|
235.32 | -16.94% | -2.2% | 34,261.86 | 0% | -10.89% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
80.40 | 142.2% | 221.62% | 15,385.96 | 0% | 32.46% |
|
NasdaqGS:INCY
Incyte
|
57.05 | 104.81% | 153.29% | 12,012.93 | 0% | 27.62% |
|
NasdaqCM:VKTX
Viking Therapeutics
|
78.01 | 0% | 0% | 8,843.51 | 0% | 0% |
|
NasdaqGS:BPMC
Blueprint Medicines
|
106.79 | 0% | 0% | 6,783.92 | 0% | 0% |
|
NasdaqGM:ARNA
Arena Pharmaceuticals
|
99.99 | 0% | 0% | 6,165.32 | 0% | 0% |
|
NasdaqGM:IOVA
Iovance Biotherapeutics
|
10.68 | 0% | 0% | 3,763.74 | 0% | 0% |
|
NasdaqGS:CCXI
ChemoCentryx
|
51.99 | 0% | 0% | 3,739.11 | 0% | 0% |
|
NasdaqGS:CBAY
CymaBay Therapeutics
|
32.44 | 0% | 0% | 3,724.47 | 0% | 0% |
|
NasdaqGS:ARWR
Arrowhead Pharmaceuticals
|
25.04 | 0% | 0% | 3,062.73 | 0% | 0% |
|
NasdaqGM:DRNA
Dicerna Pharmaceuticals
|
38.01 | 0% | 0% | 2,986.1 | 0% | 0% |
|
NasdaqGM:FOLD
Amicus Therapeutics
|
9.66 | 0% | 0% | 2,807.75 | 0% | 0% |
|
NasdaqCM:CLDX
Celldex Therapeutics
|
40.17 | 0% | 0% | 2,631.15 | 0% | 0% |
|
NasdaqGS:ACAD
ACADIA Pharmaceuticals
|
15.12 | 0% | 0% | 2,512.75 | 0% | 0% |
|
NasdaqGM:VCEL
Vericel
|
49.41 | -94.78% | -76.15% | 2,364.47 | 0% | 0% |
|
NasdaqGM:ADMA
ADMA Biologics
|
9.10 | 0% | 0% | 2,042.24 | 0% | 0% |
